Tue, 30 Jun 2015 13:17:56 GMT ~ CBMG Today Responded to the Class Action Lawsuit
[GlobeNewswire] - SHANGHAI, China and PALO ALTO, Calif. -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of new treatments for ...
Mon, 29 Jun 2015 13:00:00 GMT ~ Cellular Biomedicine Group Completes Acquisition of CD40LGVAX Vaccine
[GlobeNewswire] - SHANGHAI, China and PALO ALTO, Calif. -- Cellular Biomedicine Group Inc. ("CBMG" or the "Company"), a biomedicine firm engaged in the development of new treatments for degenerative ...
Fri, 19 Jun 2015 19:30:00 GMT ~ MONDAY DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Cellular Biomedicine Group Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of June 22, 2015
[Business Wire] - The following statement is being issued by Levi & Korsinsky, LLP:
Thu, 18 Jun 2015 18:51:57 GMT ~ The Rosen Law Firm Reminds Cellular Biomedicine Group Inc. Investors of the Important June 22, 2015 Deadline in the Class Action -- CBMG
[GlobeNewswire] - NEW YORK -- The Rosen Law Firm, a global investor rights firm, reminds purchasers of Cellular Biomedicine Group Inc. securities from June 18, 2014 through April 7, 2015 of the important June 22, 2015 lead ...
Tue, 16 Jun 2015 13:17:37 GMT ~ CBMG Selected for Inclusion in the Russell 3000 Index
[GlobeNewswire] - SHANGHAI, China and PALO ALTO, Calif. -- Cellular Biomedicine Group Inc. ("CBMG" or the "Company"), a biomedicine firm engaged in the development of effective treatments for degenerative ...
Link: http://www.otcmarkets.com/stock/CBMG/company-info Ticker: $CBMG OTC Market Place: Not Available CIK code: 0001378624 Company name: Cellular Biomedicine Group, Inc. Company website: http://www.cellbiomedgroup.com Incorporated In: DE, USA
Business Description: Cellular Biomedicine Group, Inc. (CBMG) is a biomedicine firm engaged in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell technologies, which include, without limitation, (i) haMPC (human adipose-derived mesenchymal progenitor cells) for treatment of joint disease, (ii) huMPC (human umbilical cord-derived mesenchymal progenitor cells), (iii) TC-DC (tumor cell specific dendritic cells) for treatment of a broad range of cancers and (iv) MNP (human embryo-derived motor neuron precursor cells) and NP (human embryo-derived neuronal precursor cells) for treatment of central nervous system diseases.Less >>
$CBMG share structure
## source: otcmarkets.com
Market Value: $431,926,187 a/o Jul 01, 2015 Shares Outstanding: 11,514,961 a/o May 05, 2015 Float: Not Available Authorized Shares: Not Available Par Value: Not Available
$CBMG extra dd links
Company name: Cellular Biomedicine Group, Inc. Company website: http://www.cellbiomedgroup.com